Cresco Labs Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CL.CN research report →
Price Chart
About the company
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods.
- CEO
- Charles Bachtell
- IPO
- 1996
- Employees
- 2,900
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on CL.CN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $382.56M
- P/E
- -2.61
- Fwd P/E
- 30.11
- PEG
- 0.02
- P/S
- 0.43
- P/B
- 0.82
- EV/EBITDA
- 8.06
- Div Yield
- 0.00%
- Gross Margin
- 48.41%
- Op Margin
- 9.83%
- Net Margin
- -15.88%
- ROE
- -28.27%
- ROIC
- 5.56%
Latest fiscal year · YoY change
- Revenue
- $667.33M-7.9%
- Gross Profit
- $324.57M-10.9%
- Op Income
- $76.94M
- Net Income
- $-137,778,389-85.1%
- EPS
- $-0.42-90.9%
- OCF Growth
- -44.0%
- FCF Growth
- -64.8%
- 52W High
- $3.12
- 52W Low
- $0.89
- 50D MA
- $1.07
- 200D MA
- $1.33
- Beta
- 1.72
- RSI (14)
- 53
- Avg Volume
- 101.23K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Cresco said Q1 was a baseline quarter and expects growth to accelerate through 2026 as new Pennsylvania and Ohio stores, Kentucky launch progress, and federal rescheduling tailwinds begin to flow through.· May 8, 2026
- Q1 revenue was $151 million, with $77 million of adjusted gross profit and $33 million of adjusted EBITDA; management said the quarter matched expectations and served as a 2026 baseline.
- Adjusted gross margin was 51%, adjusted SG&A was $51 million or 34% of revenue, and adjusted EBITDA margin was 22%.
- Q2 revenue is expected to increase about 10% sequentially, with gross margin guided to 48% to 50% and adjusted EBITDA margin near 21%.
- Pennsylvania was a focal point: Cresco added 9 stores via a management service agreement, bringing its Pennsylvania footprint to 27 stores, with the deal expected to close after regulatory approvals.
- Management is bullish on Kentucky and Texas as longer-term growth drivers, while Michigan remains a drag from the excise tax and pricing reset.
- Rescheduling was framed as a major industry milestone, but management said it is still too early to quantify 280E or other regulatory outcomes.
Q1 2026 revenue was $151 million. Adjusted gross profit was $77 million and adjusted EBITDA was $33 million. Adjusted gross margin was 51%, adjusted SG&A was $51 million, or 34% of revenue, and adjusted EBITDA was 22% of revenue. Year-over-year changes were not stated in the prepared remarks. For Q2, management expects revenue to increase approximately 10% sequentially, gross margin to be 48% to 50%, and adjusted EBITDA margin to be near 21%.
CEO Charles Bachtell said Cresco started 2026 with a plan to build growth from a scaled base while keeping margin and cost discipline, and he said Q1 delivered on those priorities. He emphasized strengthening leadership in core states, expanding into attractive new markets, and using rescheduling as an important step toward normalization and better industry economics. His tone was upbeat but measured: he repeatedly said it is still early on federal changes and that Cresco is in learning mode, while stressing confidence in the company’s positioning.
CFO Sharon Schuler said Q1 was the baseline quarter because of the California exit, Michigan disruption, and the timing of growth initiatives that will show up later in the year. She cited $151 million of revenue, 51% adjusted gross margin, $51 million of adjusted SG&A, and $33 million of adjusted EBITDA, and noted the company ended the quarter with $67 million in cash and restricted cash. She said Cresco used $6 million in operating cash flow and invested $11 million in capex and acquisitions, mostly for Kentucky, and guided Q2 revenue up about 10% sequentially with gross margin at 48% to 50% and EBITDA margin near 21%.
Analysts focused on Pennsylvania, asking why Cresco pursued the 9-store acquisition and how ready the state is for adult-use. Management said the deal deepens an already leading position, adds retail scale, and positions the company well for a likely adult-use catalyst, while noting there is some excess capacity but not enough for full adult-use maturity. Questions also centered on rescheduling and 280E relief; management said it is too early to know the final outcome, but they are watching for Treasury and IRS guidance and will adapt as clarity emerges. On Michigan, management said the market is still weak because the tax has not fully flowed through the system, inventory bought ahead of the tax is still moving, and the state’s low pricing may eventually lead to consolidation and better stability.
The bullish case from the call is that Cresco thinks it is entering a growth phase after a clean Q1 baseline, with sequential improvement expected in Q2 and more contribution from Pennsylvania, Ohio, Kentucky, and Texas. Management also highlighted strong operating leverage, leading wholesale positions, Sunnyside stores outperforming state averages by over 30% per store, and the possibility that rescheduling could improve profitability over time.
The main risks discussed were Michigan’s excise-tax disruption, broader pricing compression, and the fact that Q1 growth initiatives had not yet fully flowed into reported results. Management also repeatedly said federal rescheduling details, including retrospective 280E relief and broader regulatory implications, remain uncertain, and Kentucky contributions this year are expected to be modest while programs ramp. Pennsylvania adult-use timing is still unclear, and management said the new store deal may not close until later in Q2, subject to approvals.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.6%
- Shares Outstanding
- 354.23M
- Float Shares
- 345.56M
Our CL.CN coverage
Recent articles, reports, and earnings notes.
No research on CL.CN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CL.CN report →